SEC Form 4 · accession 0001209191-17-022761
AGIOS PHARMACEUTICALS, INC. · AGIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis Clayton Cantley Jr.
Director
Period of report
Mar 22, 2017
Accepted (ET)
Mar 24, 2017 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2 | Mar 22, 2017 | S | 509 | $52.31 | D | 94,769 | D | |
| Common stockF2,F3 | Mar 22, 2017 | S | 509 | $52.31 | D | 94,809 | I | See footnote |
| Common stockF4 | Mar 23, 2017 | S | 509 | $53.91 | D | 94,260 | D | |
| Common stockF4,F3 | Mar 23, 2017 | S | 509 | $53.91 | D | 94,300 | I | See footnote |
| Common stockF5 | holding | — | — | — | 25,000 | I | See footnote | |
| Common stockF6 | holding | — | — | — | 25,000 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $51.50 to $52.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3Shares held by Vicki Lee Sato, who is the reporting person's spouse.
- F4The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $53.50 to $54.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant. On December 22, 2016, the reporting person contributed 12,500 shares of common stock to the trusts.
- F6Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and her two children, of which the reporting person's spouse is trustee and sole annuitant. On December 22, 2016, the reporting person's spouse contributed 12,500 shares of common stock to the trusts.